Lack of evidence for mutation to erythromycin resistance in clinical strains of Staphylococcus aureus.
AUTOR(ES)
Lacey, R W
RESUMO
The properties of 100 erythromycin resistant strains of Staphylococcus aureus obtained from clinical material have been compared with the properties of mutants selected in vitro for resistance to erythromycin. The properties, including inducibility of the resistance and cross-resistance to spiramycin and lincomycin, of the two groups of isolates were always different. The risk that staphylococci will mutate to erythromycin resistance during therapy with this antibiotic is remote.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=476494Documentos Relacionados
- Transfer of Erythromycin Resistance from Poultry to Human Clinical Strains of Staphylococcus aureus
- Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus.
- Lack of evidence for a saturable tetracycline transport system in Staphylococcus aureus.
- Low-level methicillin resistance in strains of Staphylococcus aureus.
- Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus.
